rdf:type |
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0021027,
umls-concept:C0032181,
umls-concept:C0085297,
umls-concept:C0140430,
umls-concept:C0178602,
umls-concept:C0205171,
umls-concept:C0398650,
umls-concept:C1518321,
umls-concept:C1627892,
umls-concept:C1637379,
umls-concept:C1704419
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-5-1
|
pubmed:abstractText |
To conduct a randomized prospective trial of immune globulin treatment for 105 Rh+ children with newly-diagnosed immune thrombocytopenic purpura and a platelet count<20,000/microL, to determine whether anti-D immune globulin (anti-D) is as effective as intravenous immune globulin (IVIg).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-3476
|
pubmed:author |
pubmed-author:Acute ITP Study Group,
pubmed-author:BertoloneSalvatore JSJ,
pubmed-author:DavisMary LML,
pubmed-author:KalinyakKaren AKA,
pubmed-author:KulkarniRoshniR,
pubmed-author:LynnHenryH,
pubmed-author:NugentDiane JDJ,
pubmed-author:ShaferFrank EFE,
pubmed-author:TarantinoMichael DMD,
pubmed-author:WeberLisa CLC,
pubmed-author:YoungGuyG
|
pubmed:issnType |
Print
|
pubmed:volume |
148
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
489-94
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16647411-Adolescent,
pubmed-meshheading:16647411-Child,
pubmed-meshheading:16647411-Child, Preschool,
pubmed-meshheading:16647411-Dose-Response Relationship, Drug,
pubmed-meshheading:16647411-Female,
pubmed-meshheading:16647411-Humans,
pubmed-meshheading:16647411-Immunoglobulins, Intravenous,
pubmed-meshheading:16647411-Immunologic Factors,
pubmed-meshheading:16647411-Infant,
pubmed-meshheading:16647411-Male,
pubmed-meshheading:16647411-Platelet Count,
pubmed-meshheading:16647411-Prospective Studies,
pubmed-meshheading:16647411-Purpura, Thrombocytopenic, Idiopathic,
pubmed-meshheading:16647411-Rho(D) Immune Globulin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
|
pubmed:affiliation |
Comprehensive Bleeding Disorders Center, University of Illinois College of Medicine, Peoria, Illinois 61614, and Children's Hospital of Orange County, Orange, California, USA. mdtara@hemophilia-ctr-peoria.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|